[Trends in the treatment of bronchial asthma].
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000485:Allergens; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001249:Asthma / Q000628:therapy*; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D004205:Cromolyn Sodium / Q000627:therapeutic use*; D003888:Desensitization, Immunologic; D005938:Glucocorticoids / Q000627:therapeutic use*; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006801:Humans; D011453:Prostaglandins / Q000627:therapeutic use*; D012141:Respiratory Tract Infections / Q000188:drug therapy; D012702:Serotonin Antagonists
D000485:Allergens; D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D001993:Bronchodilator Agents; D005938:Glucocorticoids; D006634:Histamine H1 Antagonists; D011453:Prostaglandins; D012702:Serotonin Antagonists; D000324:Adrenocorticotropic Hormone; D004205:Cromolyn Sodium
Indirizzi di terapia dell'asma bronchiale